Idea

Regrow the adult human lens from the patient's own cells

Darko Savic Aug 23, 2026

Please leave the feedback on this idea

Originality

Is it original or innovative?

Feasibility

Is it feasible?

Necessity

Is it targeting an unsolved problem?

Conciseness

Is it concisely described?

Bounty for the best solution

Provide a bounty for the best solution

Bounties attract serious brainpower to the challenge.

The human lens can be regenerated from a patient's own cells. The founding proof is on record: minimally invasive lens evacuation that spares the eye's own lens epithelial cells regrew functional lenses in human infants     . The enabling technologies already exist, separately. Transient, switchable reprogramming vectors are in human ocular trials     . The newt regrows a complete lens for life through dedifferentiation          . Adult human lens cells retain proliferative, lens-protein-expressing activity in vivo; ophthalmology calls that activity "posterior capsule opacification" and ablates it. Yet no academic group or company has been located running a program aimed at reproducible adult lens regeneration with optical quality and objectively measured accommodation. As far as the public record shows, the lane is unoccupied rather than unimagined. This idea maps the evidence, names the honest bottlenecks, and lays out a milestone-gated program a small funded team can start. Plus one reframe: PCO is usually treated as a complication. Read differently, it is adult lens regeneration caught in the act - and the most abundant, ethically low-friction human model of lens regrowth available, though the usable specimen streams have to be named precisely: Nd:YAG capsulotomy ablates rather than excises and yields no tissue, capsulorhexis discs are living lens epithelial cells rather than samples of later PCO, and true PCO tissue arrives only through clinically indicated explants or research-consented donor pseudophakic eyes.
Why it matters
Cataract and presbyopia are two outcomes of one failure - unrepaired lens damage - the founding proofs already exist, and no program aimed at the cure has been located in the public record
Cataract is the leading cause of blindness worldwide. Presbyopia affects an estimated 1.8 billion people     . At root they are the same failure: an organ whose job is gradient-index optics plus time-varying biomechanics accumulates damage in proteins that no longer turn over.
Every current surgical endpoint is a static prosthesis. Spectacles and intraocular lenses manage the consequence; none restores the native organ or its dynamic focusing.
The lane is unoccupied rather than unimagined, as far as the public record shows. Reviews in 2026 now call for activating the regenerative potential of adult lens epithelial cells and extending regeneration beyond children - from Zhejiang, Stanford and elsewhere, institutions distinct from the one that ran the pediatric program, which is itself informative.                Our searches through 10 September 2026 found no publicly documented program integrating aged human tissue assays, a shared standardized adult animal model, and prespecified optical-quality and objective accommodation criteria. What exists are substitutes for a living lens: accommodating and fluid implants (Atia OmniVu, LensGen Juvene, Ocumetics), polymer bag refilling still in the lab, and drugs that soften or uncloud the old lens (the lanosterol drop line of work, whose clinical status we could not verify - no registered lanosterol cataract trial was located on ClinicalTrials.gov as of 10 September 2026, and the indexed literature is preclinical). Nothing regrows the lens itself. The field's own 2026 reviews say it plainly: regenerating a lens after age-related cataract surgery has not been accomplished, regeneration in children is slow and incomplete with a resulting risk of amblyopia and secondary surgery, and adult cataract surgery makes preserving usable lens epithelial cells harder .               
How it works
Evacuate. Remove lens fiber content through a lens-epithelial-cell- and capsule-preserving mini-capsulorhexis - the Lin paradigm that regenerated lenses in rabbits, macaques, and human infants     .
Protect. Hold the post-operative capsule environment against fibrosis with TGF-β-pathway anti-fibrotic pharmacology for the full regrowth window          . This is the explicit attempt to reproduce the newt's permissive wound environment     .
Transiently rejuvenate. Dosed, switchable factors (doxycycline-gated vectors      or redosable mRNA     ), titrated to restore proliferative and organizational vigor without identity loss     . The switch stays under external control, with a prespecified, independently verifiable off condition.
Verify against the endpoint that defines success: objectively measured accommodation     . Visual acuity will not do; pinhole optics can game it. Measure transparency, geometry, and optical power alongside. The founding pediatric study did measure this endpoint           (within the 2022-2026 window we searched, nothing has repeated it) - open-field autorefraction at near and far targets plus dynamic retinoscopy, giving a mean accommodative response of 2.5 dioptres at 8 months against 0.2 +/- 0.1 D in conventional-surgery aphakic controls. That 2.5 D is a near-complete response to a fixed near/far stimulus step of about 2.7 D, not a measurement of maximum amplitude, and accommodation was not a registered endpoint of the trial. The refractive and functional claims drew two Matters Arising in Nature in 2018          , and the authors published a reply disclaiming any claim of a completely normal regenerated lens          .
Build the infrastructure first. Fund one core to establish and distribute the adult lens-evacuation model with standardized 14/30/60-day readouts. The confirmatory trial (NCT03230799) has registry status Unknown as checked 10 September 2026 (record last updated 17 May 2022) and no posted results were located;      recover the field's missing pediatric baseline with a run-anywhere reanalysis package. Bank age-stratified discarded cataract-surgery tissue (capsulorhexis discs, phaco pellets) with paired clinical phenotype               . Run a blinded, centralized trigger bakeoff on matched donor tissue, then the research-consented donor-eye assay     . Preregistered milestones and go/no-go gates before any biology.
Where it landed
Fund infrastructure and answers, not hope. First the groundwork: a reliable adult-animal model of lens removal that any lab can use, and a rescue of the unreported confirmatory trial (NCT03230799: registry status Unknown as checked 10 September 2026, record last updated 17 May 2022, actual start 2017, estimated enrollment 100, no posted results).      Then collect the tissue that cataract surgery throws away every day, and let labs compete to find what pushes adult lens cells to regrow in an organized way instead of turning into scar tissue. The most promising triggers get tested in donated human eyes, then in animals, using factors that can be switched off from the outside. Success means a lens that not only grows clear but also focuses - measured, not assumed     . Several candidate triggers exist and the proposed combined protocol has not been tested in adults; finding out which trigger works is the whole point of the program.
Open tension
Can the eye's wound environment alone steer adult lens cells toward organized regrowth, or do the cells themselves need rejuvenation      - which carries its own cancer-adjacent risk?
Born as an idea, not a paper
This article was developed as a structured brief on the brainstorming.com platform. The full research roadmap is published alongside: Toward Reproducible Adult Lens Regeneration: An Unfunded Frontier, A Testable Framework.
Next test
Stand up the adult mammalian lens-evacuation model with LEC preservation and standardized readouts at 14/30/60+ days (refill volume, crystallin expression, transparency, optical power, EMT markers). Every later milestone gates on this one. In parallel, first establish whether NCT03230799 enrolled and whether a dataset is available for reanalysis; if so, ship its investigators (registry status Unknown as checked 10 September 2026, record last updated 17 May 2022, actual start 28 July 2017, estimated enrollment 100, no posted results) a complete     , locked reanalysis package they can run behind their own firewall. Authorship on any resulting paper follows ICMJE contribution criteria; compensation for the work is offered separately and unconditionally.
What we ruled out
Xenogeneic or stem-cell-derived lens transplantation - stacks rejection and dysplasia problems on top of regeneration; the tractable version extracts the newt's program as software and tests whether autologous, accessible, adjacent human iris pigment epithelium can run an equivalent program in situ          
Better intraocular lenses (extended-depth-of-focus, trifocal, light-adjustable) - iterates the replacement prosthesis; rational and well-funded (~$200M in 2026), but it leaves the biological question unworked. This program is the complement, not the competitor
Pharmacological presbyopia fixes (drops, femtosecond lens softening) - phase-2 misses and an in-vivo chemical-reprogramming test in mice that was associated with toxic lipid-droplet accumulation hindering rejuvenation at the tolerated dose (one cocktail, one model, an observed association rather than an established mechanism)      set the endpoint discipline this program adopts: measure accommodation objectively, never let pinhole acuity game the endpoint
A premature prize for 'first adult lens regeneration' - prizes without verifiable milestones go unclaimed or disputed; a terminal prize becomes appropriate only after the milestone ladder exists to be climbed
Risks / pre-mortem
Adult lens cells under wound conditions preferentially undergo EMT/fibrosis rather than organized differentiation - the central biological obstacle           - kill signal: the trigger bakeoff finds no candidate that moves the organized-regeneration-to-fibrosis ratio on matched donor tissue
The aged capsule itself - stiffened, glycated, contracting      - defeats optical quality even if cells regrow - kill signal: donor-eye assay regrows tissue but measured optical power stays non-functional
Reprogramming carries oncogenic-identity risk intrinsic to its mechanism - kill signal: no demonstrated externally-switchable control with a clean off-state in the adult-model core
Transparency never implied accommodation: the zonules and ciliary muscle age too, so a perfect lens may sit in a middle-aged mechanism - kill signal: regenerated lens passes transparency but the accommodation endpoint is unchanged; endpoint design must measure the system, not the tissue
Honest claims ledger
Honest claims ledger: the proposed combined protocol has not been tested in adults; the pediatric foundation still has an unrecovered confirmatory trial (NCT03230799, registry status Unknown as checked 10 September 2026, record last updated 17 May 2022, actual start 28 July 2017, estimated enrollment 100, no posted results located; recovering it is the program's first job); reading PCO as regeneration-in-progress is an interpretation rather than a consensus, though human donor histology now shows Soemmering rings with internal transparent areas      and an adult rat model shows a regenerated lens forming by day 30 alongside rising fibronectin     . The full case, including verified citations, search methodology, ethics and safety notes, is the paper 'Toward Reproducible Adult Lens Regeneration: An Unfunded Frontier, A Testable Framework' (Savic, 2026, author's edition v1.4, PDF: https://brainstorming.com/lab/ideas/adult-lens-regeneration-roadmap-savic-2026-v1.4.pdf). Author: Darko Savic (independent researcher; founder of this platform), with AI literature-synthesis assistance, disclosed.
Doors this opens
Reframe - If PCO is adult lens regeneration caught in the act, what changes when a hospital's YAG-laser ablation queue is treated as the world's largest regenerative-medicine cohort, a registry waiting to be mined instead of a complication waiting to be lasered?
Cheap test - What is the cheapest 60-day experiment that tests, under specified environmental conditions, whether adult lens cells organize - accepting that a negative result under one set of conditions cannot by itself separate intrinsic incapacity from an inadequate environment?
Wild door - A single-cell atlas of the newt iris during lens regeneration now exists (preprint)      - can that mapped program be executed by human iris pigment epithelium in situ, making the iris itself the regenerative organ?
Full paper (PDF)
Darko Savic. Toward Reproducible Adult Lens Regeneration: An Unfunded Frontier, A Testable Framework. Author's edition, v1.4, 10 September 2026 (supersedes v1.3 of 23 August 2026). Not peer reviewed. Download the PDF.

[1]Lin H, Ouyang H, Zhu J, et al. Lens regeneration using endogenous stem cells with gain of visual function. Nature. 2016;531:323-328. PMID 26958831. Open-field autorefraction and dynamic retinoscopy: mean accommodative response 2.5 +/- 0.2 D at 8 months vs 0.2 +/- 0.1 D in aphakic controls; refractive power 19.0 D; central thickness 3.7 mm. Author manuscript: https://pmc.ncbi.nlm.nih.gov/articles/PMC6061995/

[2]ClinicalTrials.gov NCT07290244. Phase 1 single-dose study of ER-100 (AAV, doxycycline-inducible OSK) in open-angle glaucoma and NAION. Recruiting; actual start 2026-03-02; primary outcomes are safety, 21 secondary outcomes include efficacy-labelled visual function; estimated primary completion 2027-05. https://clinicaltrials.gov/study/NCT07290244

[3]Williams OM, Ahearn KE, Sevigny JL, et al. A single cell atlas of the newt iris during lens regeneration. bioRxiv. 9 Dec 2025. PMID 41573855. Preprint.

[4]Suetsugu-Maki R, Maki N, Nakamura K, et al. Lens regeneration in axolotl: new evidence of developmental plasticity. BMC Biol. 2012;10:106. PMID 23244204. Corrects the usual shorthand: the axolotl does regenerate its lens, but only from hatching to about two weeks post-hatching, and from either dorsal or ventral iris.

[5]Fricke TR, Tahhan N, Resnikoff S, et al. Global prevalence of presbyopia and vision impairment from uncorrected presbyopia: systematic review, meta-analysis, and modelling. Ophthalmology. 2018;125:1490-1501. PMID 29753495.

[6]Zhong Y, Chen L, Gu Y, Yu Y, Fu Q, Yao K. Cataract: surgery first - is there still room for basic research? Adv Ophthalmol Pract Res. 2026;6(2):116-123. PMID 41938157. From Zhejiang, a different institution from the one that ran the pediatric program: calls for methods to activate adult lens-epithelial-cell regenerative potential, and attributes PCO-versus-transparent fate to the postoperative niche.

[7]Nelson A, Logan C, Manche A, Myung D. Crystalline lens regeneration: a review. Curr Ophthalmol Rep. 2026; online 19 Jan 2026. doi:10.1007/s40135-025-00346-5. The most recent comprehensive review of the field; reports a stem/progenitor-like cluster at the apex of the human lens-epithelium differentiation hierarchy - the concrete target population for any trigger comparison.

[8]Fan X, Monnier VM. Lens aging and disease: molecular mechanisms, functional consequences, and pharmacological implications. Prog Retin Eye Res. 2026;111:101446. PMID 41679456.

[9]Gu Y, Yao K, Fu Q. Lens regeneration: scientific discoveries and clinical possibilities. Mol Biol Rep. 2021;48:4911-4923. PMID 34143397.

[10]Taiyab A, West-Mays J. Lens fibrosis: cell adhesion signaling in lens epithelial-mesenchymal transition. Front Cell Dev Biol. 2022;10:886053. PMID 35656546.

[11]Rakib-Uz-Zaman SM, Werner L, Duncan MK. Unanswered questions regarding the pathogenesis of late onset posterior capsular opacification. Front Ophthalmol. 2025;5:1680042. PMID 41195341.

[12]Tsissios G, Sallese A, Perez-Estrada JR, et al. Macrophages modulate fibrosis during newt lens regeneration. Stem Cell Res Ther. 2024;15(1):141. PMID 38745238. Macrophage depletion abrogated regeneration and produced scar-like tissue: immune handling of the wound is causally upstream.

[13]Song R, Lin Y, Zhang M, et al. Ocular delivery of lipid nanoparticles-formulated mRNA encoding lanosterol synthase ameliorates cataract in rats. Nat Commun. 2025;16(1):8522. PMID 41006301. Intracameral LNP-mRNA gives sustained, lens-selective expression in vivo: a delivery precedent, not a reprogramming one.

[14]Lee J, Han M, Wang K, Butler LR, Sinclair DA. Epigenetic reprogramming for ocular aging and disease. Prog Retin Eye Res. 2026;111:101442. PMID 41577329. Retina- and optic-nerve-centric throughout. That is a statement about what this review covers, not proof that no lens-targeted reprogramming program exists anywhere.

[15]Bharadwaj SR. Ocular accommodation: the autofocus mechanism of the human eye. Annu Rev Vis Sci. 2025;11:19-41. PMID 40749145. The measurement basis for the accommodation endpoint.

[16]Corrigendum: Lens regeneration using endogenous stem cells with gain of visual function. Nature. 2017;541:558 (published online 30 November 2016). PMID 27919080. doi:10.1038/nature19831. Corrected scale-bar lengths (Fig. 3e, Extended Data Fig. 7b), misplaced molecular-weight markers (Supplementary Fig. 1), and clarified that Table 1's parenthetical decimal-acuity values are standard deviations rather than logMAR. No accommodation or refractive-power data changed. It notes that the original paper was not corrected online.

[17]Solebo AL, Hammond C, Rahi JS. Improving outcomes in congenital cataract (Matters Arising). Nature. 2018;556:E1-E2. doi:10.1038/nature26148. Full text read: the reported outcomes fall far short of expected outcomes for this population; a contemporaneous British Isles cohort (IoLunder2) achieved more than twice the result in either arm; the mean acuity reached sits at the threshold for the legal definition of blindness; eight months of partially obscured and poorly focused vision may explain the poor outcomes through deprivation amblyopia; management of a rapidly changing refractive error (18 D over 8 months) was not described; and CONSORT essentials (baseline equivalence, randomization method, power calculation, outcome hierarchy) were absent.

[18]Vavvas DG, Dryja TP, Wilson ME, Olsen TW, Shah A, Jurkunas U, et al. (23 authors). Lens regeneration in children (Matters Arising). Nature. 2018;556:E2-E3. PMID 29620729. doi:10.1038/nature26149. Raises concerns about features of the presented data and the conclusions reached. Paywalled: its precise scope is not characterized further here, and it should not be read as having specifically impugned the accommodation numbers.

[19]Liu Y, Granet D, Lin H, Baxter S, Ouyang H, Zhu J, Huang S, Liu Z, et al. (17 authors). Liu et al. reply. Nature. 2018;556:E3-E4. doi:10.1038/nature26150. Welcomes the comments and disclaims having claimed a completely normal regenerated lens.

[20]Liu Z, Wang R, Lin H, Liu Y. Lens regeneration in humans: using regenerative potential for tissue repairing. Ann Transl Med. 2020;8(22):1544. PMID 33313289. The authors' own review: the morphology and volume of the regenerated lens cannot reach the level of a normal lens.

[21]ClinicalTrials.gov NCT03230799. Comparison of minimally invasive lens surgery and traditional cataract surgery for congenital cataract. Actual start 2017-07-28; estimated enrollment 100; status Unknown as checked 2026-09-10, record last updated 2022-05-17; no posted results. https://clinicaltrials.gov/study/NCT03230799

[22]Gu Y, Chen L, Chen S, et al. A single-cell transcriptomic atlas of human lens epithelium. Stem Cell Res Ther. 2025;16(1):333. PMID 40598599. Four non-aged and four aged donors: TOP2A+ transient amplifying cells, ID1+ progenitor-like cells, pleiotrophin signaling weakened with age, markers validated in rabbit regenerated lenses.

[23]Tang Q, Tong Z, Fan C, et al. Deconstruction of human age-related cataract capsules defines aging. Adv Sci. 2026:e76532. PMID 42555200. 230,838 lens epithelial cells from 554 patients - but single-nucleus sequencing on frozen, pooled capsule discs. Procurement at scale is proven; a living, phenotype-linked bank is not.

[24]Saranya P, Shekhar M, Haripriya A, et al. Towards the identification and characterization of putative adult human lens epithelial stem cells. Cells. 2023;12(23):2727. PMID 38067155.

[25]Wormstone IM. The human capsular bag model of posterior capsule opacification. Eye (Lond). 2020;34(2):225-231. PMID 31745327. The established human ex-vivo model to adapt, not reinvent.

[26]Chen X, Wang H, Chen H, et al. Lens regeneration in situ using hESCs-derived cells - similar to natural lens. iScience. 2023;26(6):106921. PMID 37378332. Exogenous graft in rabbit, reaching about 85% of contralateral thickness with near-natural dioptric power at 54 weeks. The route this idea argues against; a rabbit graft benchmark for optical maturation that motivates extended follow-up, not a prediction for aged human endogenous regeneration.

[27]Lin W, Jia X, Shi X, et al. Reactivation of mammalian regeneration by turning on an evolutionarily disabled genetic switch. Science. 2025;388(6754):eadp0176. PMID 40570123. Not lens tissue: cited for the distinction that lost regeneration can be an activational deficit rather than lost competence.

[28]Hiramatsu N, Yamamoto N, Kato Y, et al. Formation of three-dimensional cell aggregates expressing lens-specific proteins in cultures of human iris-derived tissue cells and iPS cells. Exp Ther Med. 2022;24(2):539. PMID 35837031. First human iris anchor - conversion in culture, not yet in situ dedifferentiation.

[29]Mitchell W, de Magalhaes JP, Tyshkovskiy A, et al. In vivo chemical reprogramming is associated with a toxic accumulation of lipid droplets hindering rejuvenation. Aging Cell. 2026;25:e70390. PMID 41589348. One cocktail, one mouse model: an observed association, not an established mechanism for reprogramming in general.

[30]Li J, Yu J, Huang W, et al. Extracellular HSP90 promotes differentiation of lens epithelial cells to fiber cells by activating LRP1-YAP-PROX1 axis. FASEB J. 2023;37(2):e22783. PMID 36705056.

[31]Cooksley G, Nam MH, Nahomi RB, et al. Lens capsule advanced glycation end products induce senescence in epithelial cells. Aging Cell. 2024;23(10):e14249. PMID 39384405. The aged capsule is a cause, not a neutral container.

[32]D'Antin JC, Tresserra F, Barraquer RI, Michael R. Soemmerring's rings developed around IOLs, in human donor eyes, can present internal transparent areas. Int J Mol Sci. 2022;23(21):13294. PMID 36362082.

[33]Bi X, Wang R, Song H, et al. The miRNA-34a/Sirt1/p53 pathway in a rat model of lens regeneration. Ann Transl Med. 2022;10(11):636. PMID 35813324. Young-adult rats (8-10 weeks, n=42), 90-day course: a regenerated lens formed by day 30 while fibronectin rose. Young adults, not aged animals - which is the gap the proposed model core exists to close.

academic research scientific research eyes